The legislation will advance groundbreaking medical innovation and research that will help millions of Americans with life-threatening diseases.
The proposal recognizes the complex needs of those with multiple chronic conditions and has the potential to improve health care quality and reduce costs.
While ideological divides on health care policy remain wide, the next Congress and administration will face several key issues that will require bipartisan collaboration to address.
BPC applauds FDA’s efforts to incorporate enhancements to accelerate the development and delivery of safe and effective treatments and cures to patients.
Through its extensive research with experts and practitioners, BPC identified numerous benefits for using real-world evidence to modernize drug development.
The Senate HELP Committee held its third markup of legislation that will improve the development process and increase investment in drugs that address health needs.
The REGROW Act—which aligns with recommendations included in a recent BPC report—modernizes FDA’s current regulatory approach toward safe and effective cell therapies.
The Senate HELP Committee’s health innovation legislative package includes three bills that align with BPC’s recommendations.
Rapidly emerging new models of care delivery and payment, advances in biomedical innovation, and increasing consumer demand are driving the need for greater electronic information sharing.